Top Markets
#1 DogBull DogBull +108.53%
#2 MarsCoin MarsCoin +84.53%
#3 Siacoin Siacoin +54.45%
#4 ADO Protocol ADO Protocol +52.61%
#5 The Bitcoin Bull The Bitcoin Bull +28.19%
#6 Ontology Gas Ontology Gas +26.26%
#7 Apertum Apertum +16.17%
#8 Arowana Arowana +12.72%
#9 Pons Pons +12.09%
#10 Useless Coin Useless Coin +11.98%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Guangdong VTR Bio-Tech Co., Ltd. Guangdong VTR Bio-Tech Co., Ltd.

Guangdong VTR Bio-Tech Co., Ltd.

300381
Rank in Stocks #14712
Guangdong VTR Bio-Tech Co., Ltd. researches, develops, produces, sells, and... Guangdong VTR Bio-Tech Co., Ltd. researches, develops, produces, sells, and services bio-enzyme preparations, biosynthetics, and nutrition and health products in China and internationally. The company offers animal nutrition and health, biofuel, detergent, food and beverage, brewing, starch sweetness, bakery, plant extracts, pulp and paper, and textile enzymes, as well as biotechnology solutions. It also provides active natural products. The company also exports its products. The company was founded in 1991 and is based in Zhuhai, China.
Share Price
$0.82600914
Market Cap
$396.63M
Change (1 day)
0.00%
Change (1 year)
-20.40%
Country
CN
Trade Guangdong VTR Bio-Tech Co., Ltd. (300381)

Category

Healthcare
Revenue for Guangdong VTR Bio-Tech Co., Ltd. (300381)
Revenue in Sep 2026 TTM: 0
According to Guangdong VTR Bio-Tech Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Guangdong VTR Bio-Tech Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH